Stock FUSN FUSN PHAR
Add to a list
To use this feature you must be a member
Log inSign up

Insiders FUSN PHAR

Equities

FUSN

CA36118A1003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
21.48 USD -0.09% Intraday chart for FUSN PHAR -0.14% +123.52%
May. 09 Fusion Pharmaceuticals Inc. Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer CI
May. 07 Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fed Policy Meeting in Focus as Exchange-Traded Funds, Equity Futures Fall Pre-Bell Tuesday
MT
Fusion Pharmaceuticals Inc. Announces Board Changes
CI
Fusion Pharmaceuticals Appoints Dmitri Bobilev as Chief Medical Officer
CI
Fusion Pharmaceuticals Inc. Announces Executive Changes
CI
Insider Sell: Fusion Pharmaceuticals
MT
Insider Sell: Fusion Pharmaceuticals
MT
Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development
PR
Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development
CI
Fusion Pharmaceuticals Names Christopher Leamon as Chief Scientific Officer
MT
Fusion Pharmaceuticals Inc. Appoints Christopher Leamon as Chief Scientific Officer
CI
Fusion Pharmaceuticals : Names Mohit Rawat as President and Chief Business Officer
MT
Fusion Pharmaceuticals Appoints Mohit Rawat as President and Chief Business Officer
CI
Fusion Pharmaceuticals Inc. Appoints Eric S. Hoffman as Senior Vice President, Business Development
CI
Fusion Pharmaceuticals Inc. Appoints Isabelle Dussault as Senior Vice President, Research
CI
Fusion Pharmaceuticals Appoints Donald Bergstrom to Board of Directors
CI
Fusion Pharmaceuticals Appoints Philina Lee to Its Board of Directors
CI
Fusion Pharmaceuticals Inc. Appoints Barbara Duncan as Chairperson of the Board of Directors
CI
Fusion Pharmaceuticals Appoints Maria Stahl as Chief Legal Officer
CI
Fusion Pharmaceuticals Appoints James J. O’Leary, M.D. as Chief Medical Officer
CI
Fusion Pharmaceuticals Announces Appointment of Steven Gannon to Board of Directors and Chair of Audit Committee
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FUSN Stock
  4. News FUSN PHAR
  5. Insiders